Mechanisms of activation and inhibition of Zika virus NS2B-NS3 protease.
作者信息
Chen Xia, Yang Kailin, Wu Chen, Chen Cheng, Hu Can, Buzovetsky Olga, Wang Zefang, Ji Xiaoyun, Xiong Yong, Yang Haitao
机构信息
School of Life Sciences, Tianjin University, Tianjin 300072, China.
Tianjin International Joint Academy of Biotechnology and Medicine, Tianjin 300457, China.
出版信息
Cell Res. 2016 Nov;26(11):1260-1263. doi: 10.1038/cr.2016.116. Epub 2016 Oct 18.
Abstract
摘要
相似文献
1
Mechanisms of activation and inhibition of Zika virus NS2B-NS3 protease.
Cell Res. 2016 Nov;26(11):1260-1263. doi: 10.1038/cr.2016.116. Epub 2016 Oct 18.
2
The Structure of the Zika Virus Protease, NS2B/NS3.
Adv Exp Med Biol. 2018;1062:131-145. doi: 10.1007/978-981-10-8727-1_10.
3
Crystal structure of unlinked NS2B-NS3 protease from Zika virus.
Science. 2016 Dec 23;354(6319):1597-1600. doi: 10.1126/science.aai9309. Epub 2016 Dec 8.
4
Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship.
Biotechnol Lett. 2017 Mar;39(3):415-421. doi: 10.1007/s10529-016-2261-6. Epub 2016 Nov 24.
5
Extended substrate specificity and first potent irreversible inhibitor/activity-based probe design for Zika virus NS2B-NS3 protease.
Antiviral Res. 2017 Mar;139:88-94. doi: 10.1016/j.antiviral.2016.12.018. Epub 2016 Dec 26.
6
Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus.
Antiviral Res. 2017 Mar;139:49-58. doi: 10.1016/j.antiviral.2016.12.016. Epub 2016 Dec 26.
7
Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition.
Antiviral Res. 2018 Dec;160:118-125. doi: 10.1016/j.antiviral.2018.10.019. Epub 2018 Oct 28.
8
Zika NS2B is a crucial factor recruiting NS3 to the ER and activating its protease activity.
Virus Res. 2020 Jan 2;275:197793. doi: 10.1016/j.virusres.2019.197793. Epub 2019 Oct 29.
9
Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor.
Science. 2016 Jul 29;353(6298):503-5. doi: 10.1126/science.aag2419. Epub 2016 Jul 7.
10
Substrate profiling of Zika virus NS2B-NS3 protease.
FEBS Lett. 2016 Oct;590(20):3459-3468. doi: 10.1002/1873-3468.12443. Epub 2016 Oct 18.
引用本文的文献
1
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors.
Res Sq. 2025 Feb 13:rs.3.rs-5876218. doi: 10.21203/rs.3.rs-5876218/v1.
2
Advances in antiviral strategies targeting mosquito-borne viruses: cellular, viral, and immune-related approaches.
Virol J. 2025 Feb 4;22(1):26. doi: 10.1186/s12985-025-02622-z.
3
Evaluation of methoxyflavones as dengue NS2B-NS3 protease inhibitors: an in silico and in vitro studies.
Mol Divers. 2025 Apr;29(2):1175-1187. doi: 10.1007/s11030-024-10899-5. Epub 2025 Jan 22.
4
Discovery of Potent Dengue Virus NS2B-NS3 Protease Inhibitors Among Glycyrrhizic Acid Conjugates with Amino Acids and Dipeptides Esters.
Viruses. 2024 Dec 17;16(12):1926. doi: 10.3390/v16121926.
5
The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection.
Protein Pept Lett. 2024;31(7):532-543. doi: 10.2174/0109298665308871240703090408.
6
Recent advances in the study of zika virus structure, drug targets, and inhibitors.
Front Pharmacol. 2024 Jul 1;15:1418516. doi: 10.3389/fphar.2024.1418516. eCollection 2024.
7
A Non-Active-Site Inhibitor with Selectivity for Zika Virus NS2B-NS3 Protease.
ACS Infect Dis. 2024 Feb 9;10(2):412-425. doi: 10.1021/acsinfecdis.3c00330. Epub 2024 Jan 24.
8
Evaluating Known Zika Virus NS2B-NS3 Protease Inhibitor Scaffolds via In Silico Screening and Biochemical Assays.
Pharmaceuticals (Basel). 2023 Sep 19;16(9):1319. doi: 10.3390/ph16091319.
9
Drugs to limit Zika virus infection and implication for maternal-fetal health.
Front Virol. 2022;2. doi: 10.3389/fviro.2022.928599. Epub 2022 Aug 5.
10
Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease.
Bioorg Chem. 2023 Feb;131:106269. doi: 10.1016/j.bioorg.2022.106269. Epub 2022 Nov 19.
本文引用的文献
1
Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor.
Science. 2016 Jul 29;353(6298):503-5. doi: 10.1126/science.aag2419. Epub 2016 Jul 7.
2
Pathology of congenital Zika syndrome in Brazil: a case series.
Lancet. 2016 Aug 27;388(10047):898-904. doi: 10.1016/S0140-6736(16)30883-2. Epub 2016 Jun 29.
3
Zika virus: history of a newly emerging arbovirus.
Lancet Infect Dis. 2016 Jul;16(7):e119-e126. doi: 10.1016/S1473-3099(16)30010-X. Epub 2016 Jun 6.
4
Zika Virus as a Cause of Neurologic Disorders.
N Engl J Med. 2016 Apr 21;374(16):1506-9. doi: 10.1056/NEJMp1602708. Epub 2016 Mar 9.
5
Anticipating the international spread of Zika virus from Brazil.
Lancet. 2016 Jan 23;387(10016):335-336. doi: 10.1016/S0140-6736(16)00080-5. Epub 2016 Jan 15.
6
Zika virus genome from the Americas.
Lancet. 2016 Jan 16;387(10015):227-8. doi: 10.1016/S0140-6736(16)00003-9. Epub 2016 Jan 8.
7
The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development.
Antiviral Res. 2015 Jun;118:148-58. doi: 10.1016/j.antiviral.2015.03.014. Epub 2015 Apr 2.
8
Novel therapies for hepatitis C - one pill fits all?
Nat Rev Drug Discov. 2013 Aug;12(8):595-610. doi: 10.1038/nrd4050. Epub 2013 Jun 28.
9
Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
J Med Chem. 2008 Sep 25;51(18):5714-21. doi: 10.1021/jm800503y. Epub 2008 Aug 26.
10
Insights to substrate binding and processing by West Nile Virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies.
J Biol Chem. 2006 Dec 15;281(50):38448-58. doi: 10.1074/jbc.M607641200. Epub 2006 Oct 19.
Zotero 插件